The Swiss company SKAN is the global market and technology leader for isolators, clean room devices and decontamination processes for the aseptic production of biopharmaceutical active ingredients. SKAN's core competence is the development and construction of process isolators for the aseptic filling of biopharmaceutical products. In addition, the company offers its customers process support, services and consumables.
SKAN's technology and innovation leadership is based on the unique combination of expertise in the fields of ventilation technology, air conditioning and sterilization, software programming - which must be validated in compliance with pharmaceuticals -, microbiology and chemistry through to knowledge of regulatory requirements and manufacturing expertise.
With its state-of-the-art products and services, SKAN focuses on markets with the highest regulatory requirements in the healthcare sector. These are mainly located in Europe, North America, Japan, South Korea and Singapore. In these markets, every third vaccine produced in the isolator is filled in a SKAN isolator. In addition, sales are made in emerging markets such as China, India and Brazil. If the pharmaceutical companies there want to export to Europe and North America, they also have to meet the same high requirements of the regulatory authorities.
SKAN's expertise and innovative strength result from long-standing, trusting relationships with blue-chip (bio)pharmaceutical companies and leading research laboratories worldwide. Because SKAN's products and services are critical to customer success, the company benefits from high barriers to entry. Thanks to experts in the in-house laboratories, who research innovative solutions for isolator technology, SKAN can meet even the most complex customer requirements.
In addition to investing in technological improvements and the expansion of its production capacities, SKAN has always worked closely with its customers and developed qualification strategies to ensure rapid process approvals by the authorities. A comprehensive support program is available to ensure that the customer receives optimal support throughout the entire product life cycle. This is guaranteed by a global service network of internal and external specialists.
SKAN, which was founded in 1968 as a trading company for Scandinavian health products, today employs over 1000 people. More than half of the employees work at the Allschwil headquarters in the life sciences hub of the Basel region. The other employees are distributed among the subsidiaries in Stein (Aargau), Germany, Belgium, Japan and the USA.
